RESUMO
For understanding normal and pathological circuit function, capitalizing on the full potential of recent advances in fast optical neural circuit control will depend crucially on fast, intact-circuit readout technology. First, millisecond-scale optical control will be best leveraged with simultaneous millisecond-scale optical imaging. Second, both fast circuit control and imaging should be adaptable to intact-circuit preparations from normal and diseased subjects. Here we illustrate integration of fast optical circuit control and fast circuit imaging, review recent work demonstrating utility of applying fast imaging to quantifying activity flow in disease models, and discuss integration of diverse optogenetic and chemical genetic tools that have been developed to precisely control the activity of genetically specified neural populations. Together these neuroengineering advances raise the exciting prospect of determining the role-specific cell types play in modulating neural activity flow in neuropsychiatric disease.
Assuntos
Potenciais de Ação/fisiologia , Rede Nervosa/citologia , Rede Nervosa/fisiologia , Neurônios/citologia , Neurônios/fisiologia , Potenciais de Ação/efeitos da radiação , Animais , Diagnóstico por Imagem , Marcação de Genes , Neurônios/efeitos dos fármacos , Neurônios/efeitos da radiação , Estimulação LuminosaRESUMO
BACKGROUND: Most antidepressant medications target central monoamine systems and are often characterized by limited efficacies and unwanted side effects. Thus, significant efforts are ongoing to identify novel targets for the treatment of depression. Growing evidence suggests that neuropeptides play a role in the pathophysiology of depression. The melanin-concentrating hormone (MCH) is one such neuropeptide, implicated in the modulation of many physiological responses. METHODS: We utilized an array of techniques including chronic mild stress (CMS) as a depression paradigm, neurobehavior, gene expression analysis, and knockout genetics to investigate the role of MCH receptor subtype 1 (MCHR1) in murine models of depression. RESULTS: We report here that following a 5-week exposure to repeated chronic mild stress (an ethologically relevant animal model of depression), C57Bl/6J mice have increased hippocampal gene expression of MCH receptor subtype 1 (MCHR1), the cognate melanin concentrating hormone receptor in mice. This increased gene expression is reversed by chronic fluoxetine hydrochloride (Prozac) treatment. Additionally, while female and male mice carrying a null mutation of the MCHR1 gene show comparable anxiolytic-like behavior on the open field, only female knockout mice exhibit antidepressant-like behavior, when tested on the forced swim and tail suspension tests. CONCLUSION: Taken together, we suggest that antagonism of the MCHR1 receptor may provide a novel approach for the treatment of affective disorders, including depression, with a potentially increased efficacy in women.
Assuntos
Transtorno Depressivo/genética , Modelos Animais de Doenças , Receptores de Somatostatina/genética , Animais , Antidepressivos de Segunda Geração/farmacologia , Feminino , Fluoxetina/farmacologia , Expressão Gênica/efeitos dos fármacos , Hipocampo/efeitos dos fármacos , Hipocampo/patologia , Humanos , Masculino , Melaninas/metabolismo , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Estresse Psicológico/complicaçõesRESUMO
The biological effects of the melanin-concentrating hormone (MCH) are mediated by the melanin concentrating hormone receptor 1 (MCHR1) in mice. This receptor is enriched in brain areas that are involved in the modulation of mood and affect, suggesting that MCH-dependent signaling may influence neurobiological mechanisms underlying fear and anxiety processes. To test this, we have generated mice lacking functional MCHR1 and characterized phenotypic traits using a number of behavioral tests. Mice carrying a null mutation of the MCHR1 gene display anxiolytic-like behavior across a battery different behavioral paradigms commonly used to assess fear and anxiety responses in rodents: open field, elevated plus maze, social interaction, and stress-induced hyperthermia. The brain serotonin (5-HT) system is central to the control of mood- and anxiety-related processes. To examine the impact of MCHR1 receptor deletion on 5-HT neurotransmission, we used in vivo microdialysis in freely moving knockout and wild-type mice. Baseline dialysate 5-HT levels were significantly lower in MCHR1 knockout mice as compared with wild-type controls (9.53+/-0.24 fmol for wild types vs 6.91+/-0.36 fmol for knockouts) in the prefrontal cortex (PFC), one of the main target structures of the serotonergic system and one that is highly associated with the control of emotional processes. Moreover, forced swim increased 5-HT efflux in the PFC of wild-type but not MCHR1 knockout mice. In summary, we show that MCHR1 can modulate stress- and anxiety-like behaviors and suggest that this may be due to changes in serotonergic transmission in forebrain regions.
Assuntos
Ansiedade/genética , Receptores do Hormônio Hipofisário/genética , Animais , Comportamento Animal/fisiologia , Química Encefálica/genética , Química Encefálica/fisiologia , Cromatografia Líquida de Alta Pressão , Meio Ambiente , Espaço Extracelular/metabolismo , Febre/genética , Febre/fisiopatologia , Genótipo , Relações Interpessoais , Camundongos , Camundongos Knockout , Microdiálise , Atividade Motora/fisiologia , Fenótipo , Córtex Pré-Frontal/metabolismo , Serotonina/metabolismo , Estresse Psicológico/genética , Estresse Psicológico/fisiopatologiaRESUMO
The neurodevelopmental disorder Williams-Beuren syndrome is caused by spontaneous approximately 1.5 Mb deletions comprising 25 genes on human chromosome 7q11.23. To functionally dissect the deletion and identify dosage-sensitive genes, we created two half-deletions of the conserved syntenic region on mouse chromosome 5G2. Proximal deletion (PD) mice lack Gtf2i to Limk1, distal deletion (DD) mice lack Limk1 to Fkbp6, and the double heterozygotes (D/P) model the complete human deletion. Gene transcript levels in brain are generally consistent with gene dosage. Increased sociability and acoustic startle response are associated with PD, and cognitive defects with DD. Both PD and D/P males are growth-retarded, while skulls are shortened and brains are smaller in DD and D/P. Lateral ventricle (LV) volumes are reduced, and neuronal cell density in the somatosensory cortex is increased, in PD and D/P. Motor skills are most impaired in D/P. Together, these partial deletion mice replicate crucial aspects of the human disorder and serve to identify genes and gene networks contributing to the neural substrates of complex behaviours and behavioural disorders.
Assuntos
Deleção Cromossômica , Comportamento Social , Síndrome de Williams/genética , Animais , Encéfalo/anormalidades , Encéfalo/patologia , Cognição , Condicionamento Psicológico , Tecido Conjuntivo/patologia , Medo , Regulação da Expressão Gênica , Ventrículos do Coração/patologia , Heterozigoto , Humanos , Camundongos , Atividade Motora/fisiologia , Tamanho do Órgão , Fenótipo , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Crânio/anormalidades , Síndrome de Williams/patologia , Síndrome de Williams/fisiopatologiaRESUMO
The hippocampus is one of several brain areas thought to play a central role in affective behaviors, but the underlying local network dynamics are not understood. We used quantitative voltage-sensitive dye imaging to probe hippocampal dynamics with millisecond resolution in brain slices after bidirectional modulation of affective state in rat models of depression. We found that a simple measure of real-time activity-stimulus-evoked percolation of activity through the dentate gyrus relative to the hippocampal output subfield-accounted for induced changes in animal behavior independent of the underlying mechanism of action of the treatments. Our results define a circuit-level neurophysiological endophenotype for affective behavior and suggest an approach to understanding circuit-level substrates underlying psychiatric disease symptoms.
Assuntos
Giro Denteado/fisiopatologia , Transtorno Depressivo/fisiopatologia , Hipocampo/fisiopatologia , Rede Nervosa/fisiopatologia , Animais , Antidepressivos Tricíclicos/farmacologia , Comportamento Animal/efeitos dos fármacos , Giro Denteado/patologia , Transtorno Depressivo/patologia , Diagnóstico por Imagem , Modelos Animais de Doenças , Estimulação Elétrica , Eletrofisiologia , Feminino , Fluoxetina/farmacologia , Hipocampo/patologia , Imipramina/farmacologia , Atividade Motora/efeitos dos fármacos , Neurônios/citologia , Neurônios/fisiologia , Ratos , Ratos Endogâmicos F344 , Inibidores Seletivos de Recaptação de Serotonina/farmacologia , Estresse Fisiológico/fisiopatologiaRESUMO
Neuronal excitotoxicity causes energetic impairment and the ensuing cell death has historically been regarded as necrotic. Recent findings, however, indicate that apoptosis may participate in excitotoxicity. Here we examined the neuroprotective mechanisms of the well-characterized viral caspase inhibitors, p35 and crmA, following domoic acid-induced excitotoxicity in hippocampal neurons. We show that though p35 and crmA rescued neurons from toxicity, they did so under conditions of negligible caspase activation and morphological apoptosis. Thus, we characterized the novel neuroprotective effects of p35 and crmA and found that they attenuated the drop in the mitochondrial potential and blunted the decline in ATP levels. These data, to our knowledge, are the first detailed descriptions of the cell death mechanisms following domoic acid treatment of neurons. Moreover, in demonstrating the previously unexplored modulation of these processes, these data underline the capacity for classically "anti-apoptotic" proteins to alter other branches of cell death processes.
Assuntos
Inibidores de Caspase , Inibidores de Cisteína Proteinase/farmacologia , Ácido Caínico/análogos & derivados , Fármacos Neuroprotetores/farmacologia , Serpinas/farmacologia , Proteínas Virais/farmacologia , Animais , Caspase 1/metabolismo , Caspase 3 , Caspases/metabolismo , Células Cultivadas , Chlorocebus aethiops , Ativação Enzimática/efeitos dos fármacos , Ativação Enzimática/fisiologia , Vetores Genéticos/farmacologia , Ácido Caínico/toxicidade , Potenciais da Membrana/efeitos dos fármacos , Potenciais da Membrana/fisiologia , Necrose , Ratos , Ratos Sprague-Dawley , Simplexvirus/química , Células VeroRESUMO
Both endogenous and exogenous glucocorticoids (GCs) are known to cause apoptosis in a number of peripheral tissues and in some cases in the CNS. Additionally, GCs can exacerbate the neuron loss associated with such acute neurological insults as hypoxia-ischemia, excitotoxicity, and metabolic disruption. This exacerbation is accompanied by increased accumulation of glutamate in the synapse, excessive cytosolic calcium, and increased oxygen radical activity, markers usually attributed to pathways of necrotic cell death. It is also known that acute insults can involve apoptotic mediators. In this context, one outstanding question that has received little attention is whether the exacerbation of insult-mediated cell death in neurons is apoptotic in mechanism. In this study we investigate whether the GC-mediated exacerbation of hippocampal excitotoxicity in culture involves apoptosis. Specifically, we show that while the magnitude of hippocampal neuron death caused by the excitotoxin kainic acid is indeed worsened in the presence of GCs, there is no evidence of increased markers of apoptosis. Specifically, we show that neither kainic acid nor GCs alone, or in combination, cause activation of caspase 3, a critical executor of insult-induced apoptosis. Furthermore, while kainic acid causes a significant incidence of apoptotic nuclear condensation, the incidence of this morphological indicator of apoptosis is not worsened by GCs. Thus, GCs appear to augment excitotoxic death in hippocampal neurons without augmenting the occurrence of apoptosis. We suggest that this finding is to be expected, given some energetic features of GC action and the energetic demands of apoptosis.